MicroRNAs and their delivery in diabetic fibrosis

A Wonnacott, L Denby, RJM Coward, DJ Fraser… - Advanced drug delivery …, 2022 - Elsevier
The global prevalence of diabetes mellitus was estimated to be 463 million people in 2019
and is predicted to rise to 700 million by 2045. The associated financial and societal costs of …
被引用次数：29 相关文章

MicroRNAs and their delivery in diabetic fibrosis

A Wonnacott, L Denby, RJM Coward… - Advanced drug …, 2022 - pubmed.ncbi.nlm.nih.gov
The global prevalence of diabetes mellitus was estimated to be 463 million people in 2019
and is predicted to rise to 700 million by 2045. The associated financial and societal costs of …

MicroRNAs and their delivery in diabetic fibrosis.

A Wonnacott, L Denby, RJM Coward… - Advanced Drug …, 2021 - europepmc.org
The global prevalence of diabetes mellitus was estimated to be 463 million people in 2019
and is predicted to rise to 700 million by 2045. The associated financial and societal costs of …

MicroRNAs and their delivery in diabetic fibrosis

A Wonnacott, L Denby, RJM Coward… - Advanced Drug …, 2022 - orca.cardiff.ac.uk
The global prevalence of diabetes mellitus was estimated to be 463 million people in 2019
and is predicted to rise to 700 million by 2045. The associated financial and societal costs of …

MicroRNAs and their delivery in diabetic fibrosis

A Wonnacott, L Denby… - Advanced Drug …, 2022 - research-information.bris.ac.uk
The global prevalence of diabetes mellitus was estimated to be 463 million people in 2019
and is predicted to rise to 700 million by 2045. The associated financial and societal costs of …

MicroRNAs and Their Delivery in Diabetic Fibrosis

A Wonnacott, L Denby, RJM Coward… - Advanced Drug …, 2021 - research.ed.ac.uk
The global prevalence of diabetes mellitus was estimated to be 463 million people in 2019
and is predicted to rise to 700 million by 2045. The associated financial and societal costs of …